Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians
Author(s) -
Kevin C. Brown,
Mina C. Hosseinipour,
Janelle M. Hoskins,
Ranjit K. Thirumaran,
Hsiao-Chuan Tien,
Ralf Weigel,
Jean Tauzie,
Ida Shumba,
Jatinder K. Lamba,
Erin G. Schuetz,
Howard L. McLeod,
Angela D. M. Kashuba,
Amanda Corbett
Publication year - 2011
Publication title -
pharmacogenomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.541
H-Index - 91
eISSN - 1744-8042
pISSN - 1462-2416
DOI - 10.2217/pgs.11.132
Subject(s) - nevirapine , cyp2b6 , cyp3a4 , pharmacogenetics , constitutive androstane receptor , genotype , pharmacokinetics , pregnane x receptor , cyp2a6 , single nucleotide polymorphism , pharmacology , allele , cyp3a , cyp3a5 , biology , medicine , cytochrome p450 , genetics , gene , viral load , nuclear receptor , metabolism , virus , antiretroviral therapy , transcription factor
Genetic polymorphisms have the potential to influence drug metabolism and vary among ethnic groups. This study evaluated the correlation of genetic polymorphisms with nevirapine pharmacokinetics exposure in Malawians.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom